Conference presentation videos, research grants review and more in this issue of Microscope.
Nearly 100 participants attended the 2nd Annual “Road to a Cure: The Latest Developments in Blood Cancer Research,” hosted by the Leukemia Research Foundation (LRF) at Cancer Wellness Center in Northbrook, Ill. on Wednesday, May 2. Information about lymphomas, chronic lymphocytic leukemia (CLL),
An LRF-funded researcher studies new AML and MDS drug and a free patient program in this issue of Microscope.
Wintrust joins list of event sponsors committed to fighting blood cancers. (NORTHFIELD, Ill.) April 17, 2018 — Wintrust, a financial services company based in Rosemont, Ill., has signed on to be Presenting Sponsor of the ABC 7 Gibbons 5K Run and 3K Walk, benefitting the Leukemia Research
Congratulations to former Leukemia Research Foundation Nurse of the Year Linda Rivard, RN, BSN, CPON. Nurse Rivard was featured in a Daily Southtown article recently about the program she started at Advocate Children’s Hospital in Oak Lawn, Ill. The program, Pediatric Oncology Survivors in
An LRF-funded researcher discusses CLL in a video and an AML patient shares her story in this issue of Microscope.
An LRF-funded researcher shares in $10 million New Innovator Award in this issue of Microscope.
Congratulations to Zhiqiang Qin, M.D., Ph.D., Assistant Professor of Microbiology, Immunology, and Parasitology at Louisiana State University Health New Orleans, who is part of a team of researchers that earned a five-year, 10 million New Innovator Award from the National Institute of General
An LRF-funded researcher earns a large research awards; round two of research funding process begins and a child's leukemia inspires A Beautiful Choice in this issue of Microscope.
One of the objectives for the Leukemia Research Foundation (LRF) in supporting research projects submitted by New Investigators is for those individuals to advance their research and, as a result, receive continued support in larger amounts from other funders. Jiwang Zhang, M.D., Ph.D.,